{"symbol":"GILD","fiscalQuarter":"Q1-2018","reportDate":"2018-05-01","reportTime":"AMC","status":"reported","company":{"name":"Gilead Sciences, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/GILD/earnings/Q1-2018","postBrief":{"headline":"Gilead Sciences Misses on EPS \u2014 Stock Down N/A%","keyNumbers":[{"metric":"EPS","actual":"$1.48","expected":"N/A","surprise":"-12.52%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing efforts to enhance product pipeline.","They expressed confidence in long-term growth despite current challenges."],"summary":"Management remains focused on strategic initiatives to drive future growth. They acknowledged the current quarter's performance but emphasized their commitment to improving results."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Gilead Sciences reported earnings that fell short of expectations, particularly in EPS. The lack of revenue data and guidance may leave investors uncertain about the company's future performance. The stock reaction is currently unavailable, but the management's cautious tone suggests they are aware of the challenges ahead and are working on strategies to address them.","metaDescription":"Gilead Sciences (GILD) Q1 2018 earnings: EPS missed expectations. Stock reaction not available. Full breakdown."}}